Blog

August 12, 2021

How to address patient privacy and data-security concerns in clinical trials

Data security and privacy concerns remain one of the biggest barriers holding patients from participating in clinical trials.* With the public awareness about data security and privacy growing, it is more important then ever to pro-actively address these concerns. 

This blog first gives a background about the recent rise of public concerns (and patients concerns specifically) about online data security and privacy. Secondly, the ways that these concerns impact clinical trial participation are mapped. Finally, we will show how we address this with our patient-centric clinical trial database ClinLife.

June 2, 2021

Decentralized Clinical Trials: A patient-centric way forward

Throughout history, adversity often gave rise to innovation as we adapted to new challenges. Although the COVID-19 pandemic set back clinical trials – as 80% of non-COVID-19 trials were stopped or interrupted – it also spurred a revolution in how clinical trials are conductedDuring the pandemic, prospective patients were unable or reluctant to visit physical research sites, while some sites paused ongoing trials as capabilities were shifted to critical care resources. The pandemic also further amplified socioeconomic disparities and made it more difficult to reach diverse patient populations, requiring stakeholders to further rethink and redesign the coordination of clinical trials.  

Trial continuation
April 8, 2021

Global Patient Insights during COVID-19 – Effects on Trial Continuation

We at Clariness strongly believe that it is crucial to better understand what’s important to patients and their needs during these challenging times. That’s why we conducted a survey in which we asked more than 17,000 patients from 21 countries a range questions across several topics, including a subgroup of people who are currently enrolled in a clinical trial on whether their participation is somehow affected by the pandemic.

wellbeing
March 9, 2021

Global Patient Insights during COVID-19 – Effects on Patient Wellbeing

The global health crisis due to the coronavirus pandemic has changed the world in ways no one could have anticipated. We live in extraordinary times with lots of challenges. We have to constantly adapt and make compromises due to ever-changing rules and regulations, which now form part of our daily lives.

COVID-19 Survey
February 11, 2021

COVID-19 Study Recruitment – how to find the right study candidates

As the COVID-19 pandemic spread through communities across the world, Clariness was faced with the unique opportunity to use our expertise to help pharmaceutical companies find a solution for people suffering from COVID-19.
COVID-19 case study
February 2, 2021

Recruitment support for COVID-19 trials

Are you and your team well prepared to meet your recruitment targets during the COVID-19 pandemic?

 

Clariness Marketplace
December 6, 2020

ClinLife marketplace – Securely speeding up clinical trials has never been that easy!

Since its foundation 15 years ago, Clariness’ mission has been to provide patients with easy access to clinical trials. This lead to the idea to digitalize, raise awareness and build up a community around clinical trials resulting in the patient portal ClinLife.

PatientsVoice2020
December 1, 2020

5th Patient ́s Voice Conference 2021

Clariness is proud to announce that its highly well received Patient´s Voice Conference will take place on March 25th 2021. Due to the pandemic, this year’s event will be held virtually. We hope this will allow even more people to have the opportunity to attend Patient’s Voice Conference.

School Ghana
November 30, 2020

Clariness “takes steps” to support a new school

Clariness believes that education is a key step to success. For the past 7 years, Clariness has supported education projects in a remote village near Sunyani, Ghana.

press_release_CLARINESS_COVID
November 24, 2020

Clariness supports COVID-19 studies

Clariness is doing its part to support and accelerate the world-wide release of a safe Covid-19 vaccine through its patient recruitment services for clinical trials.